Cheol K. Park
Hwasun, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A class act: HDAC1- Malat1 regulates MDSC apoptosis and cell cycling to decrease suppression of T cells.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors.
Journal: Translational lung cancer research
Published: November 24, 2022
Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: June 26, 2022
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea.
Journal: Anticancer research
Published: December 28, 2021
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
Journal: The oncologist
Published: May 28, 2021
Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment.
Journal: Thoracic cancer
Published: February 18, 2021
Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery.
Journal: Journal of clinical medicine
Published: October 10, 2020
Vitiligo-like depigmentation after pembrolizumab treatment in patients with non-small cell lung cancer: a case report.
Journal: Translational lung cancer research
Published: September 21, 2020
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer.
Journal: Journal of Korean medical science
Published: August 31, 2018
Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression.
Journal: Tuberculosis and respiratory diseases
Published: August 25, 2018
What is Currently the Best for Adenocarcinoma without Driver Mutation?
Journal: Tuberculosis and respiratory diseases
Published: March 22, 2018
Last Updated: 09/26/2026